New award for RSV vaccine with moderna US, INC. Base year ordering period is october 1, 2025 to september 30, 2026 with four one-year options.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79725D0052
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 52% complete
IDV ceiling
$86,670,525.05
Award type
Single award
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Moderna US, Inc. on October 1, 2025, for Respiratory Syncytial Virus (RSV) vaccine supply with a ceiling value of $86,670,525.05 and an ultimate completion date of September 30, 2027.

The contract carries no set-aside. The base year ordering period runs October 1, 2025 through September 30, 2026, with four one-year option periods. The originating solicitation, RFP #36E79725R0043, sought RSV vaccines for distribution across multiple federal agencies including the VA, State Veterans Homes, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. Offerors were required to propose exact drug names as labeled with unique NDC numbers and offer all commercial package sizes at uniform per-dose pricing. Estimated annual usage was 248,803 vials, with the vaccine serving as a mandatory source unless clinically inappropriate for specific patient populations. Distribution will occur through VA and DoD Pharmaceutical Prime Vendor Programs.

The contract falls under NAICS code 325412 (Pharmaceutical Preparation Manufacturing). A modification incorporated Section 5 of Executive Order 14398 and FAR clause 52.222-90, addressing discrimination in employment and contracting practices, effective April 2026.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00005 · Modification to incorporate section 5 of EO 14398, clause 52.222-90, addressing DEI discrimination by federal contractors (APR 2026), into the contract. $0
Exercise an Option P00004 · Exercise option year 1, effective october 1, 2026 - september 30, 2027, for RSV vaccine with moderna US, INC., contract 36E79725D0052. $0
Add Subcontract Plan P00003 · Incorporation of 2026 small business subcontracting plan into contract 36E79725D0052 - RSV vaccine. $0
Other Administrative Action P00002 · Incorporation of 2026 federal ceiling prices into contract 36E79725R0043 - RSV vaccine. The awarded national contract prices remain unchanged. $0
Supplemental Agreement for work within scope P00001 · Modification to incorporate NDC changes and add a new NDC/package to the existing contract. $0
Original award $0

Quick answers

Who was awarded contract 36E79725D0052?

36E79725D0052 was awarded to Moderna US, Inc. by National Acquisition Center (Headquarters) on October 1, 2025.

How much is contract 36E79725D0052 worth?

36E79725D0052's own ceiling is $86,670,525.

Who can order from contract 36E79725D0052?

36E79725D0052 is a single award indefinite delivery contract.

Was contract 36E79725D0052 competed?

The extent of competition for 36E79725D0052 was full and open competition. The government received 4 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login